Evidence map›Paper›PMID 38235076›Full record

ArticleNanoscale advances2024

Nano-modified screen-printed electrode-based electrochemical immunosensors for oral cancer biomarker detection in undiluted human serum and saliva samples.

Payal Gulati, Avinash Kumar Singh, Amit K Yadav, Kiran Pasbola, Prerna Pandey, Rinu Sharma, Alok Thakar, Pratima R Solanki

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Saliva-based molecular diagnostics in oral squamous cell carcinoma (OSCC): a non-invasive frontier in oncology.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Payal GulatiNano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University New Delhi-110067 India partima@mail.jnu.ac.in pratimarsolanki@gmail.com.
Avinash Kumar SinghNano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University New Delhi-110067 India partima@mail.jnu.ac.in pratimarsolanki@gmail.com.ORCID https://orcid.org/0000-0003-3626-1643
Amit K YadavNano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University New Delhi-110067 India partima@mail.jnu.ac.in pratimarsolanki@gmail.com.ORCID https://orcid.org/0000-0002-2347-3746
Kiran PasbolaUniversity School of Biotechnology, Guru Gobind Singh Indraprastha University India.
Prerna PandeyUniversity School of Biotechnology, Guru Gobind Singh Indraprastha University India.
Rinu SharmaUniversity School of Biotechnology, Guru Gobind Singh Indraprastha University India.
Alok ThakarAll India Institute of Medical Sciences Ansari Nagar New Delhi 110029 India.
Pratima R SolankiNano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University New Delhi-110067 India partima@mail.jnu.ac.in pratimarsolanki@gmail.com.ORCID https://orcid.org/0000-0003-1679-2180
Jawaharlal Nehru University · INGuru Gobind Singh Indraprastha University · INAll India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This proposed work reports the development of in-house made conductive ink-based screen-printed electrodes (SPEs) for label-free detection of oral cancer biomarkers. Carbon ink synthesis includes graphite powder, gum arabic, and water. The selectivity test of the fabricated SPE involves immobilizing antibodies specific to biomarkers and challenges with redox-active interference, other serum molecules, and non-target biomarkers. Three different biomarkers, cytokeratin-19 fragment (CYFRA 21-1), interleukin 8 (IL-8), and tumor protein p53 (TP-53), act as target entities for the detection of oral cancer in patients' samples (serum,

Identifiers

PMID38235076
PMCPMC10791120
OpenAlexW4389194387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.